Skip to content
Screener

Erasca, Inc. ERAS EPS (Basic)

EPS (Basic) at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$1.62+153%
Eli Lilly logo
Eli LillyLLY
$7.95+26.2%
Pfizer logo
PfizerPFE
-$0.04-108%
Amgen logo
AmgenAMGN
$4.40+65.4%
Revolution Medicines, Inc. logo
Revolution Medicines, Inc.RVMD
-$3.06-134%
Tango Therapeutics logo
Tango TherapeuticsTNGX
-$0.32+11.1%

Other financials

Income statement

See full
Operating income-$187.9M-427%
Net income-$183.4M-492%
EPS (diluted)-$0.60-445%

Balance sheet

See full
Cash & equivalents$47.3M-33.0%
Total debt$46.0M-9.6%
Total equity$393.5M-1.5%
Total assets$461.2M-2.1%

Cash flow

See full
Operating cash flow-$27.4M+13.2%
CapEx$36.0K-56.6%
Free cash flow-$27.4M+13.3%

Valuation

See full
Market cap$6.34B+1,466%
Enterprise value$6.34B+1,533%

Returns & leverage

See full
Return on equity-69.9%+77.1pp
Debt / equity0.1×0.0×
Current ratio9.5×-2.8×

Where this comes from

Reported directly by Erasca, Inc. in its filing.

Tagged under the XBRL concept us-gaap:EarningsPerShareBasic.

The source filing: Erasca, Inc.’s 10-Q, filed May 11, 2026.

Filed
May 11, 2026, 4:13 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-216788
Line itemThree Months Ended March 31, 2026Three Months Ended March 31, 2025
Other income (expense), net22(76)
Total other income (expense), net4,4714,664
Net loss$(183,440)$(30,966)
Net loss per share, basic and diluted$(0.60)$(0.11)
Weighted-average shares of common stock used in computing net loss per share, basic and diluted304,317,460283,260,289
Other comprehensive income (loss):
Unrealized (loss) gain on marketable securities, net(1,327)223
Comprehensive loss$(184,767)$(30,743)

Item 1. Financial Statements.

FAQ

What is Erasca, Inc.'s EPS (basic)?
Erasca, Inc. (ERAS) reported EPS (basic) of -$0.60 in Q1 2026.
How has Erasca, Inc.'s EPS (basic) changed year-over-year?
Erasca, Inc.'s EPS (basic) decreased by 445.5% year-over-year, from -$0.11 to -$0.60.
What is the long-term trend for Erasca, Inc.'s EPS (basic)?
Over 3 years (2022 to 2025), Erasca, Inc.'s EPS (basic) has grown at a -39.5% compound annual growth rate (CAGR), from -$1.99 to -$0.44.
What does EPS (basic) mean?
Net income available to common shareholders divided by the weighted-average number of common shares outstanding during the period. Does not account for dilutive securities.

Ask your AI about Erasca, Inc.'s eps (basic).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude